Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

Clinical trial NCT03294694 · TERMINATED

Trial details

NCT number: NCT03294694
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer HER2-Negative Breast Cancer Metastatic Epithelial Ovarian Cancer

Start date: 2017-11-08
Primary completion: 2020-10-14
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.